The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery

References

• Chen S, Fan J, Qiu W, et al. (2018). A cellular/intranuclear dual-targeting nanoplatform based on gold nanostar for accurate tumor photothermal therapy. J Mater Chem B 6:1–12.
   Web of Science ®Google Scholar
• Chen X, Hu X, Hu J, et al. (2020). Celastrol-loaded galactosylated liposomes effectively inhibit AKT/c-Met-triggered rapid hepatocarcinogenesis in mice. Mol Pharm 17:738–47.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang Y, Tang C, et al. (2017). Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis. Int J Pharm 529:102–15.
   PubMed Web of Science ®Google Scholar
• Delbridge AR, Grabow S, Strasser A, Vaux DL. (2016). Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer 16:99–109.
   PubMed Web of Science ®Google Scholar
• Fang J, Islam W, Maeda H. (2020). Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers. Adv Drug Deliv Rev 157:142–60.
   PubMed Web of Science ®Google Scholar
• Fu X, Mao Q, Zhang B, et al. (2022). Thiazolidinedione-based structure modification of celastrol provides thiazolidinedione-conjugated derivatives as potent agents against non-small-cell lung cancer cells through a mitochondria-mediated apoptotic pathway. J Nat Prod 85:1147–56.
   PubMed Web of Science ®Google Scholar
• Garantziotis S, Savani RC. (2019). Hyaluronan biology: a complex balancing act of structure, function, location and context. Matrix Biol 78–79:1–10.
   PubMed Web of Science ®Google Scholar
• Hu C, Zhuang W, Yu T, et al. (2020). Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy. J Mater Chem B 8:5267–79.
   PubMed Web of Science ®Google Scholar
• Huang L,Sun Z,Shen Q, et al. (2022). Rational design of nanocarriers for mitochondria-targeted drug delivery. Chin Chem Lett 33:4146–56.
   Web of Science ®Google Scholar
• Kashyap D, Sharma A, Tuli HS, et al. (2018). Molecular targets of celastrol in cancer: recent trends and advancements. Crit Rev Oncol Hematol 128:70–81.
   PubMed Web of Science ®Google Scholar
• Li H,Zhang J,Sun L, et al. (2015). Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study. Cell Death Dis 6:e1604.
   PubMed Web of Science ®Google Scholar
• Li P, He W, Yuan P, et al. (2015). Celastrol induces mitochondria-mediated apoptosis in hepatocellular carcinoma Bel-7402 cells. Am J Chin Med 43:137–48.
   PubMed Web of Science ®Google Scholar
• Li J, Jia Y, Zhang P, et al. (2020). Celastrol self-stabilized nanoparticles for effective treatment of melanoma. Int J Nanomedicine 15:1205–14.
   PubMed Web of Science ®Google Scholar
• Li X, Wang H, Ding J, et al. (2019). Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells. Eur J Pharmacol 842:146–56.
   PubMed Web of Science ®Google Scholar
• Luo Z, Dai Y, Gao H. (2019). Development and application of hyaluronic acid in tumor targeting drug delivery. Acta Pharm Sin B 9:1099–112.
   PubMed Web of Science ®Google Scholar
• Medatwal N, Ansari MN, Kumar S, et al. (2020). Hydrogel-mediated delivery of celastrol and doxorubicin induces a synergistic effect on tumor regression via upregulation of ceramides. Nanoscale 12:18463–75.
   PubMed Web of Science ®Google Scholar
• Qin Y, Liu T, Guo M, et al. (2020). Mild-heat-inducible sequentially released liposomal complex remodels the tumor microenvironment and reinforces anti-breast-cancer therapy. Biomater Sci 8:3916–25.
   PubMed Web of Science ®Google Scholar
• Saneja A, Arora D, Kumar R, Dubey RD, et al. (2018). CD44 targeted PLGA nanomedicines for cancer chemotherapy. Eur J Pharm Sci 121:47–58.
   PubMed Web of Science ®Google Scholar
• Su E, Chu Y, Chueh F, et al. (2019). Bufalin induces apoptotic cell death in human nasopharyngeal carcinoma cells through mitochondrial ROS and TRAIL Pathways. Am J Chin Med 47:237–57.
   PubMed Web of Science ®Google Scholar
• Tagami T,Nakamura K,Shimizu T, et al. (2009). Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production. J Control Release 137:234–40.
   PubMed Web of Science ®Google Scholar
• Tan Y, Zhu Y, Zhao Y, et al. (2018). Mitochondrial alkaline pH-responsive drug release mediated by Celastrol loaded glycolipid-like micelles for cancer therapy. Biomaterials 154:169–81.
   PubMed Web of Science ®Google Scholar
• Wang Y,Hong J,Shi M, et al. (2021). Triphenyl phosphate disturbs the lipidome and induces endoplasmic reticulum stress and apoptosis in JEG-3 cells. Chemosphere 275:129978.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Li X, Mao J, et al. (2022). Reverse anti-breast cancer drug resistance effects by a novel two-step assembled nano-celastrol medicine. Nanoscale 14:7856–63.
   PubMed Web of Science ®Google Scholar
• Xu J, Shamul J, Wang H, et al. (2020). Targeted heating of mitochondria greatly augments nanoparticle-mediated cancer chemotherapy. Adv Healthc Mater 9:e2000181.
   PubMed Web of Science ®Google Scholar
• You C, Wu H, Gao Z, et al. (2018). Subcellular co-delivery of two different site-oriented payloads based on multistage targeted polymeric nanoparticles for enhanced cancer therapy. J Mater Chem B 6:6752–66.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liang H, Yao H, et al. (2019). The preparation, characterization of Lupeol PEGylated liposome and its functional evaluation in vitro as well as pharmacokinetics in rats. Drug Dev Ind Pharm 45:1052–60.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang Y, Liu X, et al. (2021). Aspirin eugenol ester ameliorates paraquat-induced oxidative damage through ROS/p38-MAPK-mediated mitochondrial apoptosis pathway. Toxicology 453:152721.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Liu X, Zhao P, et al. (2020). Celastrol suppresses glioma vasculogenic mimicry formation and angiogenesis by blocking the PI3K/Akt/mTOR signaling pathway. Front Pharmacol 11:25.
   PubMed Web of Science ®Google Scholar
• Zielonka J, Joseph J, Sikora A, et al. (2017). Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem Rev 117:10043–120.
   PubMed Web of Science ®Google Scholar